Cargando…

Characterization of a Suppressive Cis-acting Element in the Epstein–Barr Virus LMP1 Promoter

Latent membrane protein 1 (LMP1) is a major oncogene encoded by Epstein–Barr virus (EBV) and is essential for immortalization of B cells by the virus. Previous studies suggested that several transcription factors, such as PU.1, RBP-Jκ, NFκB, EBF1, AP-2 and STAT, are involved in LMP1 induction; howev...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yoshida, Masahiro, Murata, Takayuki, Ashio, Keiji, Narita, Yohei, Watanabe, Takahiro, Masud, H. M. Abdullah Al, Sato, Yoshitaka, Goshima, Fumi, Kimura, Hiroshi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2017
Materias:	Microbiology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5702780/ https://www.ncbi.nlm.nih.gov/pubmed/29213259 http://dx.doi.org/10.3389/fmicb.2017.02302

Ejemplares similares

The Epstein-Barr Virus BRRF1 Gene Is Dispensable for Viral Replication in HEK293 cells and Transformation
por: Yoshida, Masahiro, et al.
Publicado: (2017)

The C-Terminus of Epstein-Barr Virus BRRF2 Is Required for its Proper Localization and Efficient Virus Production
por: Watanabe, Takahiro, et al.
Publicado: (2017)

Initial Characterization of the Epstein–Barr Virus BSRF1 Gene Product
por: Yanagi, Yusuke, et al.
Publicado: (2019)

Antitumor activity of cyclin‐dependent kinase inhibitor alsterpaullone in Epstein‐Barr virus‐associated lymphoproliferative disorders
por: Watanabe, Takahiro, et al.
Publicado: (2019)

Heat Shock Protein 90 Inhibitors Repress Latent Membrane Protein 1 (LMP1) Expression and Proliferation of Epstein-Barr Virus-Positive Natural Killer Cell Lymphoma
por: Murata, Takayuki, et al.
Publicado: (2013)

Epstein-Barr Virus BBRF2 Is Required for Maximum Infectivity
por: Masud, H. M. Abdullah Al, et al.
Publicado: (2019)

Elimination of LMP1-expressing cells from a monolayer of gastric cancer AGS cells
por: Sato, Yoshitaka, et al.
Publicado: (2017)

BGLF2 Increases Infectivity of Epstein-Barr Virus by Activating AP-1 upon De Novo Infection
por: Konishi, Natsuno, et al.
Publicado: (2018)

Role of latent membrane protein 1 in chronic active Epstein–Barr virus infection-derived T/NK-cell proliferation
por: Ito, Takuto, et al.
Publicado: (2014)

Deletion of Viral microRNAs in the Oncogenesis of Epstein–Barr Virus-Associated Lymphoma
por: Kimura, Hiroshi, et al.
Publicado: (2021)

Regulation of Epstein-Barr Virus Life Cycle and Cell Proliferation by Histone H3K27 Methyltransferase EZH2 in Akata Cells
por: Ichikawa, Takaya, et al.
Publicado: (2018)

Tofacitinib induces G1 cell-cycle arrest and inhibits tumor growth in Epstein-Barr virus-associated T and natural killer cell lymphoma cells
por: Ando, Shotaro, et al.
Publicado: (2016)

A Herpesvirus Specific Motif of Epstein-Barr Virus DNA Polymerase Is Required for the Efficient Lytic Genome Synthesis
por: Narita, Yohei, et al.
Publicado: (2015)

Molecular Basis of Epstein–Barr Virus Latency Establishment and Lytic Reactivation
por: Murata, Takayuki, et al.
Publicado: (2021)

Role of Epstein–Barr Virus C Promoter Deletion in Diffuse Large B Cell Lymphoma
por: Mabuchi, Seiyo, et al.
Publicado: (2021)

Epstein-Barr Virus BBLF1 Mediates Secretory Vesicle Transport to Facilitate Mature Virion Release
por: Uddin, Md Kamal, et al.
Publicado: (2023)

Direct Evidence of Abortive Lytic Infection-Mediated Establishment of Epstein-Barr Virus Latency During B-Cell Infection
por: Inagaki, Tomoki, et al.
Publicado: (2021)

Epstein–Barr virus LMP2A imposes sensitivity to apoptosis
por: Swanson-Mungerson, Michelle, et al.
Publicado: (2010)

Epstein-Barr Virus LMP1 Modulates the CD63 Interactome
por: Cheerathodi, Mujeeb, et al.
Publicado: (2021)

Transcriptome Changes Induced by Epstein-Barr Virus LMP1 and LMP2A in Transgenic Lymphocytes and Lymphoma
por: Shair, Kathy H. Y., et al.
Publicado: (2012)

Anti-tumor effects of suberoylanilide hydroxamic acid on Epstein–Barr virus-associated T cell and natural killer cell lymphoma
por: Siddiquey, Mohammed NA, et al.
Publicado: (2014)

Growth Transformation of B Cells by Epstein-Barr Virus Requires IMPDH2 Induction and Nucleolar Hypertrophy
por: Sugimoto, Atsuko, et al.
Publicado: (2023)

Evaluation of LMP1 of Epstein-Barr virus as a therapeutic target by its inhibition
por: Hannigan, Adele, et al.
Publicado: (2010)

The Role of Epstein-Barr Virus LMP-1 Immunohistochemical Staining in Childhood Hodgkin Lymphoma
por: Tanyildiz, Hikmet Gulsah, et al.
Publicado: (2015)

Epstein–Barr virus tegument protein BGLF2 in exosomes released from virus-producing cells facilitates de novo infection
por: Sato, Yoshitaka, et al.
Publicado: (2022)

Epstein-Barr Virus LMP2A Reduces Hyperactivation Induced by LMP1 to Restore Normal B Cell Phenotype in Transgenic Mice
por: Vrazo, Alexandra C., et al.
Publicado: (2012)

Therapeutic vaccine targeting Epstein-Barr virus latent protein, LMP1, suppresses LMP1-expressing tumor growth and metastasis in vivo
por: Lin, Mei-Chun, et al.
Publicado: (2017)

Epstein–Barr Virus LMP1 Induces Soluble PD-L1 in Nasopharyngeal Carcinoma
por: Kase, Kina, et al.
Publicado: (2021)

Replication of Epstein-Barr Virus Primary Infection in Human Tonsil Tissue Explants
por: Gotoh, Kensei, et al.
Publicado: (2011)

Antitumor effects of duvelisib on Epstein–Barr virus‐associated lymphoma cells
por: Kawada, Jun‐ichi, et al.
Publicado: (2018)

Activation of EHF via STAT3 phosphorylation by LMP2A in Epstein‐Barr virus–positive gastric cancer
por: Li, Wenzhe, et al.
Publicado: (2021)

Epstein-Barr virus: the molecular virology and the associated diseases
por: Murata, Takayuki
Publicado: (2023)

The Epstein-Barr Virus Oncoprotein, LMP1, Regulates the Function of SENP2, a SUMO-protease
por: Selby, Thomas L., et al.
Publicado: (2019)

Targeting Epstein–Barr virus oncoprotein LMP1-mediated glycolysis sensitizes nasopharyngeal carcinoma to radiation therapy
por: Xiao, L, et al.
Publicado: (2014)

Changes in Expression Induced by Epstein-Barr Virus LMP1-CTAR1: Potential Role of bcl3
por: Edwards, Rachel Hood, et al.
Publicado: (2015)

Detection of Epstein-Barr Virus by PCR and Expression of LMP1, p53, CD44 in Gastric Cancer
por: Lee, Myung Ah, et al.
Publicado: (2004)

Epstein–Barr Virus Epidemiology, Serology, and Genetic Variability of LMP-1 Oncogene Among Healthy Population: An Update
por: Smatti, Maria K., et al.
Publicado: (2018)

Identification and characterization of a novel Epstein-Barr Virus-encoded circular RNA from LMP-2 Gene
por: Tan, Ke-En, et al.
Publicado: (2021)

Epstein-Barr virus infection-induced inflammasome activation in human monocytes
por: Torii, Yuka, et al.
Publicado: (2017)

Molecular Screening for Epstein-Barr virus (EBV): Detection of Genomic EBNA-1, EBNA-2, LMP-1, LMP-2 Among Vietnamese Patients with Nasopharyngeal Brush Samples
por: Lao, Thuan Duc, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_8c56megiorinhp2dtuvmaabban